Vantage Oncology intends to price $50 million tap of 9½% secured notes due 2017 on Thursday

By Paul A. Harris

Portland, Ore., Oct. 31 - Vantage Oncology, LLC plans to price a $50 million add-on to its 9½% senior secured notes due June 15, 2017 (existing ratings B2/B) on Thursday following a mid-morning investor conference call, according to an informed source.

Jefferies LLC is the bookrunner for the Rule 144A and Regulation S for life offering.

The notes become callable on June 15, 2014 at 107.125.

The Manhattan Beach, Calif.-based owner and operator of radiation oncology centers plans to use the proceeds to refinance its credit facility, to finance an acquisition and for general corporate purposes.

The original $250 million issue priced at par on May 22.

The add-on notes will be immediately fungible with the original notes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.